DKBmed Podcasts – Medical Education Podcasts
Volume 4, Issue 3, Part 2.
Mark S. Sulkowski from the Johns Hopkins University School of Medicine interviews Dr. Graham Foster from Queen Mary University of London about the ASTRAL-3 study.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 4, Issue 3, Part 1.
Mark S. Sulkowski from the Johns Hopkins University School of Medicine interviews Dr. Vincent Leroy from Grenoble University Hospital about the ALLY-3+ study.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 4, Issue 2.
David L. Wyles, MD covers the important topic of New DAAs and HCVV Genotype 2/3 Patients in the format of case-study scenarios for the clinical practice.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Special Edition 2014, Issue 2, Part 3.
Raymond T. Chung, MD from Massachusetts General Hospital in Boston interviews Dr. Susanna Naggie from Duke University Medical Center and Dr. Paul Kwo from Indiana University School of Medicine about HCV-HIV coinfection, decompensated cirrhosis, liver transplantation and discusses strategies to treat this hard-to-treat patient subpopulation with program director, Dr. Mark Sulkowski.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Special Edition 2014, Issue 2, Part 2.
Raymond T. Chung, MD from Massachusetts General Hospital in Boston interviews Dr. Susanna Naggie from Duke University Medical Center and Dr. Paul Kwo from Indiana University School of Medicine about HCV-HIV coinfection, decompensated cirrhosis, liver transplantation and discusses strategies to treat this hard-to-treat patient subpopulation with program director, Dr. Mark Sulkowski.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Special Edition 2014, Issue 2, Part 1.
Raymond T. Chung, MD from Massachusetts General Hospital in Boston interviews Dr. Susanna Naggie from Duke University Medical Center and Dr. Paul Kwo from Indiana University School of Medicine about HCV-HIV coinfection, decompensated cirrhosis, liver transplantation and discusses strategies to treat this hard-to-treat patient subpopulation with program director, Dr. Mark Sulkowski.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Special Edition 2014, Issue 1, Part 2.
Mark S. Sulkowski, MD from Johns Hopkins University School of Medicine in Baltimore discusses patients who have genotype 3 or cirrhosis, are interferon-ineligible/intolerant, or have failed previous therapy with program director, Dr. Raymond Chung.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Special Edition 2014, Issue 1, Part 1.
Mark S. Sulkowski, MD from Johns Hopkins University School of Medicine in Baltimore interviews Dr. David Nelson from the University of Florida about patients who have genotype 3 or cirrhosis, are interferon-ineligible/intolerant, or have failed previous therapy.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 3, Issue 12.
Mark S. Sulkowski, MD, Professor of Medicine, Medical Director, Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine, Raymond T. Chung, Associate Professor of Medicine, Harvard Medical School, Director of Hepatology, Vice Chief of Gastroenterology at Massachusetts General Hospital, and Laurent Castera, MD, PhD, Department of Hepatology, Beaujon Hospital, AP-AP, INSERM U773 at the University of Paris-Diderot. Discuss new information presented at the 2014 European Association for the Study of the Liver (EASL) meeting, as well as non-invasive markers of liver disease.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 3, Issue 10.
David Thomas, MD, Professor of Medicine, and Director of the Division of Infectious Diseases at the Johns Hopkins University School of Medicine discusses HCV screening and natural history, in the form of case-study scenarios for the clinical practice.
Podcast (eviralhepatitis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS